https://www.selleckchem.com/pr....oducts/nsc697923.htm
Metabolic-associated fatty liver disease (MAFLD) is the most common liver disease globally, and affects about a quarter of the general population. Autoimmune hepatitis (AIH) is a severe (sometimes fatal) liver disease that affects children and adults, with a rising prevalence. Thus, not surprisingly, both conditions can frequently coexist, with potential synergistic impact on the course of the disease and response to therapy of both entities. In this work, the authors aimed to provide a narrative updated review on this interaction, di
Like
Comment
Share
